# Energy–Biosensor Synergy: Intrinsic Catalytic Reactions as Label-Free Signal Pathways

**Authors:** Seyyed Mehdi Khoshfetrat, Samaneh Mirsian, Amirreza Khodadadian, Wolfgang Hilber, Clemens Heitzinger

PMC · DOI: 10.3390/s26041205 · Sensors (Basel, Switzerland) · 2026-02-12

## TL;DR

This review explores how energy-driven reactions can replace traditional labels in biosensors, simplifying detection and improving performance for various applications.

## Contribution

The paper introduces energy-based electrochemical reactions as a novel, label-free alternative to conventional electroactive labels in biosensing.

## Key findings

- Energy-based reactions like HER and ORR provide intrinsic electrochemical signals without synthetic redox mediators.
- These reactions simplify assay design and improve compatibility with diverse target molecules.
- Energy-driven approaches offer faster operation and lower costs compared to traditional methods.

## Abstract

The selection of appropriate signal labels is a central consideration in electrochemical biosensing as it directly determines the achievable detection limits, dynamic range, and overall analytical performance. Conventional electroactive labels require low operating potentials, fast electron-transfer kinetics, and reliable attachment to electrode surfaces or recognition elements. Despite their extensive use, these labels present notable challenges for point-of-care applications, particularly in the detection of small molecules where target binding does not inherently generate a measurable electrochemical output. As a result, most sensing architectures depend on externally added redox reporters, introduced either freely into solution or covalently linked to recognition structures, which increases assay complexity and limits scalability. These limitations have motivated the transition toward energy-based electrochemical signal pathways, such as the hydrogen evolution reaction (HER), oxygen reduction reaction (ORR), and water-splitting reactions. These reactions provide intrinsic electrochemical outputs that eliminate the need for synthetic redox mediators and can operate as built-in catalytic signal sources. Their integration into biosensing platforms simplifies assay design, enhances robustness, and broadens compatibility with diverse target molecules. This review outlines the mechanistic basis connecting HER/ORR/water-splitting reactions to signal generation in biosensors and highlights material design principles that enable their use as reagentless and label-free transduction strategies. Compared with traditional electroactive labels, energy-driven approaches offer simplicity, reduced cost, faster operation, and improved suitability for commercial translation. By establishing a unified framework for energy-based electro-recording mechanisms, this review aims to promote the development of next-generation bioanalytical methods that operate without electroactive labels and expand the applicability of electrochemical biosensing across various domains.

## Full-text entities

- **Genes:** SOD1 (superoxide dismutase 1) [NCBI Gene 6647] {aka ALS, ALS1, HEL-S-44, IPOA, SOD, STAHP}, RHBDD3 (rhomboid domain containing 3) [NCBI Gene 25807] {aka C22orf3, HS984G1A, PTAG}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, CEACAM5 (CEA cell adhesion molecule 5) [NCBI Gene 1048] {aka CD66e, CEA}, AFP (alpha fetoprotein) [NCBI Gene 174] {aka AFPD, FETA, HPAFP}, ACSM3 (acyl-CoA synthetase medium chain family member 3) [NCBI Gene 6296] {aka SA, SAH}, SLC5A8 (solute carrier family 5 member 8) [NCBI Gene 160728] {aka AIT, SMCT, SMCT1}, EPCAM (epithelial cell adhesion molecule) [NCBI Gene 4072] {aka Ber-Ep4, BerEp4, DIAR5, EGP-2, EGP314, EGP40}, NPS (neuropeptide S) [NCBI Gene 594857], ALPP (alkaline phosphatase, placental) [NCBI Gene 250] {aka ALP, PALP, PLAP, PLAP-1}, SETBP1 (SET binding protein 1) [NCBI Gene 26040] {aka MRD29, SEB}, KLK3 (kallikrein related peptidase 3) [NCBI Gene 354] {aka APS, KLK2A1, PSA, hK3}, RASSF1 (Ras association domain family member 1) [NCBI Gene 11186] {aka 123F2, NORE2A, RASSF1A, RDA32, REH3P21}, APOE (apolipoprotein E) [NCBI Gene 348] {aka AD2, APO-E, ApoE4, LDLCQ5, LPG}, CASP3 (caspase 3) [NCBI Gene 836] {aka CPP32, CPP32B, SCA-1}, MUC1 (mucin 1, cell surface associated) [NCBI Gene 4582] {aka ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3}
- **Diseases:** cancer (MESH:D009369), infection (MESH:D007239), AD (MESH:D000544), thyroid cancer (MESH:D013964), TMDs (MESH:D013651), injury to (MESH:D014947), colon adenocarcinoma (MESH:D003110), papillary thyroid cancer (MESH:D000077273)
- **Chemicals:** nile blue (MESH:C008619), theobromine (MESH:D013805), Se (MESH:D012643), C (MESH:D002244), PC- (MESH:C053518), ascorbic acid 2-phosphate (MESH:C011669), aminobenzoic acid (MESH:D062365), Streptomycin (MESH:D013307), hydrazine (MESH:C029424), HQ (MESH:C031927), amine (MESH:D000588), PVA (MESH:C063253), OTA (MESH:C025589), sulfo-NHS (MESH:C465543), CdTe (MESH:C028337), nitrogen (MESH:D009584), carbon nitride (MESH:C011206), CNT (MESH:D037742), CTAB (MESH:D000077286), MOF (MESH:D000073396), ferrocene (MESH:C004998), fluorescein (MESH:D019793), GO (MESH:C000628730), thiol (MESH:D013438), PGE (MESH:D011458), chalcogen (MESH:D018011), O (MESH:D010100), TC (MESH:D013752), Ru (MESH:D012428), proton (MESH:D011522), chitosan (MESH:D048271), phosphate (MESH:D010710), black phosphorus (MESH:D010758), PSS (MESH:C003321), formate (MESH:C030544), PCA (MESH:D011066), NaCl (MESH:D012965), Au (MESH:D006046), polybrominated diphenyl ether (MESH:D055768), S (MESH:D013455), ferrocenium (MESH:C064804), FAM (MESH:C031179), Te (MESH:D013691), ferricyanide (MESH:C007931), silicon (MESH:D012825), Au NP (-), Metal (MESH:D008670), superoxide (MESH:D013481), hydrogen peroxide (MESH:D006861), Platinum (MESH:D010984), Graphene (MESH:D006108), Hemin (MESH:D006427), EDC (MESH:C024565), glycine (MESH:D005998), leucomethylene blue (MESH:C011010), platinum oxide (MESH:C514637), NaOH (MESH:D012972), BDE-47 (MESH:C511295), DMSA (MESH:D004113), anthraquinone (MESH:D000880)
- **Species:** Homo sapiens (human, species) [taxon 9606], Canis lupus familiaris (dog, subspecies) [taxon 9615], Mus musculus (house mouse, species) [taxon 10090], Escherichia coli O157:H7 (no rank) [taxon 83334], Leishmania (subgenus) [taxon 38568], Escherichia coli O157 (serogroup) [taxon 1045010], Human immunodeficiency virus 1 (no rank) [taxon 11676], Oryctolagus cuniculus (domestic rabbit, species) [taxon 9986]
- **Cell lines:** CA19-9 — Homo sapiens (Human), Huntington's disease, Induced pluripotent stem cell (CVCL_VC90), Caco-2 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0025)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12944496/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12944496/full.md

## References

207 references — full list in the complete paper: https://tomesphere.com/paper/PMC12944496/full.md

---
Source: https://tomesphere.com/paper/PMC12944496